{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:08:24Z","timestamp":1770883704864,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd009733.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T00:00:00Z","timestamp":1458000000000}}],"reference-count":80,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009733.pub3","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T15:49:48Z","timestamp":1458056988000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders"],"prefix":"10.1002","volume":"2016","author":[{"given":"Lise J","family":"Estcourt","sequence":"first","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Desborough","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Haematology\/Transfusion Medicine; Level 2, John Radcliffe Hospital Headington Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan J","family":"Brunskill","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; Level 2, John Radcliffe Hospital Headington Oxford Oxon UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Doree","sequence":"additional","affiliation":[{"name":"NHS Blood and Transplant; Systematic Review Initiative; Level 2, John Radcliffe Hospital Headington Oxford Oxon UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Hopewell","sequence":"additional","affiliation":[{"name":"University of Oxford; Oxford Clinical Trials Research Unit; NDORMS Windmill Road Oxford Oxfordshire UK OX3 7LD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F","family":"Murphy","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals and the University of Oxford; NHS Blood and Transplant; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; John Radcliffe Hospital Headington Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J","family":"Stanworth","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust and the University of Oxford; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; John Radcliffe Hospital, Headley Way Headington Oxford UK OX3 9BQ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,3,15]]},"reference":[{"issue":"8655","key":"10.1002\/14651858.CD009733.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(89)90181-5","article-title":"Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia","volume":"334","author":"Avvisati","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD009733.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1537-2995.1991.31491213301.x","article-title":"Lack of efficacy of tranexamic acid in thrombocytopenic bleeding","volume":"31","author":"Fricke","year":"1991","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0003|cit3","first-page":"202a","article-title":"Antifibrinolytic therapy for bleeding control during remission induction for acute leukemia","volume":"62","author":"Gallardo","year":"1983","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0004|cit4","first-page":"547a","article-title":"A controlled trial of tranexamic acid (TA) treatment for reduction of bleeding during acute myeloid leukemia (AML) induction and consolidation","volume":"82","author":"Shpilberg","year":"1993","journal-title":"Blood"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10428199509059668","article-title":"A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia","volume":"19","author":"Shpilberg","year":"1995","journal-title":"Leukemia and Lymphoma"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00000542-200302000-00011","article-title":"Antifibrinolytic therapy and perioperative blood loss in cancer patients undergoing major orthopedic surgery","volume":"98","author":"Amar","year":"2003","journal-title":"Anesthesiology"},{"issue":"21","key":"10.1002\/14651858.CD009733.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1002\/cncr.28253","article-title":"Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies","volume":"119","author":"Antun","year":"2013","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1001\/archinte.1989.00390090039008","article-title":"Control of bleeding in patients with immune and non-immune thrombocytopenia with aminocaproic acid","volume":"149","author":"Bartholomew","year":"1989","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1592\/phco.31.11.1092","article-title":"Management of menorrhagia associated with chemotherapy-induced thrombocytopenia in women with hematologic malignancy","volume":"11","author":"Bates","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S1010-7940(01)01016-8","article-title":"Aprotinin reduces postoperative bleeding and the need for blood products in thoracic surgery: results of a randomized double-blind study","volume":"20","author":"Bedirhan","year":"2001","journal-title":"European Journal of Cardio-thoracic Surgery"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-0609.1990.tb00423.x","article-title":"Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions","volume":"45","author":"Ben-Bassat","year":"1990","journal-title":"European Journal of Haematology"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2011.08922.x","article-title":"The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia","volume":"156","author":"Breen","year":"2011","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1046\/j.1365-2516.2002.00653.x","article-title":"Haemostasis: from bench to bedside","volume":"8","author":"Brown","year":"2002","journal-title":"Haemophilia"},{"issue":"2","key":"10.1002\/14651858.CD009733.pub3-BIB0014|cit14","first-page":"P","article-title":"Quality of life (QOL) evaluation in women with menorrhagia and abnormal hemostasis testing participating in a cross-over study of intranasal desmopressin and oral tranexamic acid","volume":"5","author":"Byams","year":"2007","journal-title":"Journal of Thrombosis and Hemostasis"},{"issue":"43","key":"10.1002\/14651858.CD009733.pub3-BIB0015|cit15","first-page":"2037","article-title":"Trial of epsilon-amino-caproic acid in patients with a bleeding disorder, in particular thrombocytopenic disorders","volume":"71","author":"Cattan","year":"1963","journal-title":"La Presse Medicale"},{"issue":"5","key":"10.1002\/14651858.CD009733.pub3-BIB0016|cit16","first-page":"637","article-title":"The role of antifibrinolytic agents in gynecologic cancer surgery","volume":"27","author":"Celebi","year":"2006","journal-title":"Saudi Medical Journal"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-0609.1998.tb01046.x","article-title":"Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia","volume":"60","author":"Chakrabarti","year":"1998","journal-title":"European Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD009733.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0885-3924(96)00202-3","article-title":"Fibrinolytic inhibitors for cancer-associated bleeding problems","volume":"3","author":"Dean","year":"1997","journal-title":"Journal of Pain and Symptom Management"},{"issue":"28","key":"10.1002\/14651858.CD009733.pub3-BIB0019|cit19","first-page":"1368","article-title":"Cyklokapron (tranexamic acid) in the treatment of patients with advanced neoplasms","volume":"98","author":"Fossa","year":"1978","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"1","key":"10.1002\/14651858.CD009733.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.1980.03300270023023","article-title":"Aminocaproic acid: use in control of hemorrhage in patients with amegakaryocytic thrombocytopenia","volume":"243","author":"Gardner","year":"1980","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1600-0609.1985.tb02818.x","article-title":"Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients","volume":"35","author":"Garewal","year":"1985","journal-title":"Scandinavian Journal of Haematology"},{"issue":"2","key":"10.1002\/14651858.CD009733.pub3-BIB0022|cit22","first-page":"174","article-title":"Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery","volume":"85","author":"Jeserschek","year":"2003","journal-title":"Journal of Bone and Joint Surgery"},{"issue":"1","key":"10.1002\/14651858.CD009733.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/cncr.21958","article-title":"Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage","volume":"107","author":"Kalmadi","year":"2006","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0024|cit24","first-page":"236","article-title":"The effects of intraoperative aprotinin on perioperative haemostasis and fibrinolysis and their effects on blood loss and transfusion requirements in lung surgery","volume":"25","author":"Katzel","year":"1998","journal-title":"Infusionstherapie und Transfusionsmedizin"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0025|cit25","first-page":"43","article-title":"Novel concepts in treatment and prevention of bleeding","volume-title":"IARS Review Course Lectures","author":"Levy","year":"2005"},{"issue":"6","key":"10.1002\/14651858.CD009733.pub3-BIB0026|cit26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008562.pub2","article-title":"Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia","author":"Marti-Carvajal","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009733.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3109\/17453674.2011.623568","article-title":"Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray","volume":"82","author":"McConnell","year":"2011","journal-title":"Acta Orthopaedica"},{"issue":"4","key":"10.1002\/14651858.CD009733.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.knee.2011.06.004","article-title":"Reducing blood loss in primary knee arthroplasty: a prospective randomised controlled trial of tranexamic acid and fibrin spray","volume":"19","author":"McConnell","year":"2012","journal-title":"Knee"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0029|cit29","first-page":"325","article-title":"Tranexamic acid in prevention of oropharyngeal radiomucositis","volume":"69","author":"Mevio","year":"1983","journal-title":"La Radiologia Medica"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijgo.2011.07.015","article-title":"Effects of intravenous tranexamic acid administration on blood loss during and after cesarian delivery","volume":"115","author":"Movafegh","year":"2011","journal-title":"International Journal of Gynecology and Obstetrics"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0031|cit31","unstructured":"Chung M TXA study in major oncologic surgery ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/bmt.2014.287","article-title":"Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage","volume":"50","author":"Rathi","year":"2015","journal-title":"Bone Marrow Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD009733.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0049-3848(07)70137-8","article-title":"Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?","volume":"120","author":"Rickles","year":"2007","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1002\/14651858.CD009733.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0049-3848(10)70013-X","article-title":"Open issues on bleeding and thrombosis in acute promyelocytic leukemia","volume":"125","author":"Sanz","year":"2010","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-105-6-873","article-title":"Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency","volume":"105","author":"Schwartz","year":"1986","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hon.867","article-title":"Acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients","volume":"26","author":"Wassenaar","year":"2008","journal-title":"Hematological Oncology"},{"issue":"10","key":"10.1002\/14651858.CD009733.pub3-BIB0037|cit37","first-page":"590","article-title":"Clinical study on the efficacy of tranexamic acid in reducing postpartum blood loss: a randomized, comparative, multicenter trial","volume":"36","author":"Yang","year":"2001","journal-title":"Chinese Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0038|cit38","unstructured":"NCT02578901 American Trial Using Tranexamic Acid in Thrombocytopenia (A-TREAT) ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0039|cit39","unstructured":"NCT02074436 PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) (PROBLEMA) ClinicalTrials.gov"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0040|cit40","unstructured":"ISRCTN 73545489 A double blind, randomised controlled TRial EvaluAting the safety and efficacy of Tranexamic acid in patients with haematological malignancies with severe Thrombocytopenia (TREATT) ISRCTN registry"},{"issue":"1","key":"10.1002\/14651858.CD009733.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2141.2003.04468.x","article-title":"Guidelines for the use of platelet transfusions","volume":"122","author":"British Committee for Standards in Haematology","year":"2003","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0042|cit42","volume-title":"The 2011 Annual SHOT Report","author":"Bolton-Maggs PHB (editor) and Cohen H on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group","year":"2012"},{"issue":"2","key":"10.1002\/14651858.CD009733.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1537-2995.2007.01090.x","article-title":"Evaluation of platelet transfusion triggers in a tertiary-care hospital","volume":"47","author":"Cameron","year":"2007","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0044|cit44","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD009733.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0887-7963(98)80061-8","article-title":"Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature","volume":"12","author":"Faught","year":"1998","journal-title":"Transfusion Medicine Reviews"},{"issue":"22","key":"10.1002\/14651858.CD009733.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009733.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1055\/s-0030-1254048","article-title":"Disseminated intravascular coagulation in hematologic malignancies","volume":"36","author":"Franchini","year":"2010","journal-title":"Seminars in Thrombosis and Haemostasis"},{"issue":"1","key":"10.1002\/14651858.CD009733.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfusion Medicine Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009733.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1537-2995.2007.01089.x","article-title":"Platelet utilisation and the transfusion trigger: a prospective analysis","volume":"72","author":"Greeno","year":"2007","journal-title":"Transfusion"},{"issue":"5","key":"10.1002\/14651858.CD009733.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"e18987","DOI":"10.1371\/journal.pone.0018987","article-title":"Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial","volume":"6","author":"Guerriero","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1002\/14651858.CD009733.pub3-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009052.pub2","article-title":"Methods to decrease blood loss and transfusion requirements for liver transplantation","author":"Gurusamy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/9781444311761.ch6","article-title":"Chapter 6: Investigation of acute transfusion reactions","volume-title":"Practical Transfusion Medicine","author":"Heddle","year":"2009"},{"issue":"3","key":"10.1002\/14651858.CD009733.pub3-BIB0053|cit53","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001886.pub4","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","author":"Henry","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0054|cit54","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0055|cit55","unstructured":"Higgins JPT Deeks JJ Altman DG (editors) Chapter 16: Special topics in Statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0056|cit56","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"e3054","DOI":"10.1136\/bmj.e3054","article-title":"Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis","volume":"344","author":"Ker","year":"2012","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD009733.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1200\/JCO.2005.03.8877","article-title":"Thromboembolism in hospitalized neutropenic cancer patients","volume":"24","author":"Khorana","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0059|cit59","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD009733.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-3148.2009.00911.x","article-title":"The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies","volume":"19","author":"Llewelyn","year":"2009","journal-title":"Transfusion Medicine"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0061|cit61","first-page":"567","article-title":"Avoiding platelet transfusions","volume-title":"Platelet Transfusion Therapy","author":"Lozano","year":"2013"},{"issue":"5","key":"10.1002\/14651858.CD009733.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0030-1250645","article-title":"Comparison of blood-sparing efficacy of epsilon-aminocaproic acid and tranexamic acid in newborns undergoing cardiac surgery","volume":"59","author":"Martin","year":"2011","journal-title":"The Thoracic and Cardiovascular Surgeon"},{"issue":"6","key":"10.1002\/14651858.CD009733.pub3-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001421.pub2","article-title":"Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia","author":"Martin-Hirsch","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009733.pub3-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007872.pub2","article-title":"Tranexamic acid for preventing postpartum haemorrhage","author":"Novikova","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD009733.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-2007-996127","article-title":"Enzyme-controlling medicines: introduction","volume":"23","author":"Okamoto","year":"1997","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0066|cit66","first-page":"17","article-title":"An audit of the use and wastage in the North West of England and North Wales - where have all the platelets gone?","volume":"34","author":"Pendry","year":"2011","journal-title":"Blood and Transfusion Matters"},{"issue":"6","key":"10.1002\/14651858.CD009733.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0197-2456(97)00051-2","article-title":"Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis","volume":"18","author":"Pogue","year":"1997","journal-title":"Controlled Clinical Trials"},{"issue":"6","key":"10.1002\/14651858.CD009733.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1537-2995.1985.25686071434.x","article-title":"Diagnostic and pathogenetic considerations in transfusion-related acute lung injury","volume":"25","author":"Popovsky","year":"1985","journal-title":"Transfusion"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jcp.33.Suppl_14.35","article-title":"Basis of antifibrinolytic therapy","volume":"14","author":"Prentice","year":"1980","journal-title":"Journal of Clinical Pathology Supplement"},{"issue":"9771","key":"10.1002\/14651858.CD009733.pub3-BIB0070|cit70","first-page":"1096-101, 1101.","article-title":"The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial","volume":"377","author":"Roberts","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD009733.pub3-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001245","article-title":"Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage","author":"Roos","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD009733.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.thromres.2009.06.034","article-title":"Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality","volume":"124","author":"Sawamura","year":"2009","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0073|cit73","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"9734","key":"10.1002\/14651858.CD009733.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD009733.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1002\/14651858.CD009733.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009733.pub3-BIB0077|cit77","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD009733.pub3-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006883.pub2","article-title":"Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children","author":"Tzortzopoulou","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD009733.pub3-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009733","article-title":"Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders","author":"Wardrop","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD009733.pub3-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009733.pub2","article-title":"Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders","author":"Wardrop","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd009733.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009733.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T04:02:43Z","timestamp":1722916963000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009733.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Haematological Malignancies Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,15]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009733.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,15]]}}}